NO971495L - Svekkede virus og fremgangsmåte til deres fremstilling - Google Patents
Svekkede virus og fremgangsmåte til deres fremstillingInfo
- Publication number
- NO971495L NO971495L NO971495A NO971495A NO971495L NO 971495 L NO971495 L NO 971495L NO 971495 A NO971495 A NO 971495A NO 971495 A NO971495 A NO 971495A NO 971495 L NO971495 L NO 971495L
- Authority
- NO
- Norway
- Prior art keywords
- processes
- preparation
- attenuated viruses
- attenuated
- viruses
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title 1
- 230000002238 attenuated effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16051—Methods of production or purification of viral material
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Plant Pathology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/319,974 US20030104576A1 (en) | 1994-10-07 | 1994-10-07 | Dna construct, composition, formulations & methods for making the construct & for modulating expression |
| PCT/US1995/013219 WO1996011280A1 (en) | 1994-10-07 | 1995-10-05 | Attenuated viruses and method of making the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO971495D0 NO971495D0 (no) | 1997-04-02 |
| NO971495L true NO971495L (no) | 1997-05-26 |
Family
ID=23244339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO971495A NO971495L (no) | 1994-10-07 | 1997-04-02 | Svekkede virus og fremgangsmåte til deres fremstilling |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20030104576A1 (no) |
| EP (1) | EP0784692A1 (no) |
| JP (1) | JPH10507077A (no) |
| KR (1) | KR970706399A (no) |
| CN (1) | CN1169161A (no) |
| CA (1) | CA2201487A1 (no) |
| MX (1) | MX9702524A (no) |
| NO (1) | NO971495L (no) |
| NZ (1) | NZ295070A (no) |
| WO (1) | WO1996011280A1 (no) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6982253B2 (en) | 2002-06-05 | 2006-01-03 | Supergen, Inc. | Liquid formulation of decitabine and use of the same |
| WO2005115450A1 (en) * | 2004-05-26 | 2005-12-08 | Biovaxim Limited | Compositions comprising demethylating agents as enhancers of immunotherapy for the treatment of chronic infections and neoplastic diseases and methods for treating the same |
| US7250416B2 (en) | 2005-03-11 | 2007-07-31 | Supergen, Inc. | Azacytosine analogs and derivatives |
| US7700567B2 (en) | 2005-09-29 | 2010-04-20 | Supergen, Inc. | Oligonucleotide analogues incorporating 5-aza-cytosine therein |
| CN101045946B (zh) * | 2007-04-29 | 2010-09-29 | 深圳市疾病预防控制中心 | Hiv基因检测芯片及其制备方法 |
| AR063866A1 (es) * | 2007-11-20 | 2009-02-25 | Consejo Nac Invest Cient Tec | Un procedimiento para la obtencion de cepas virales atenuadas |
| CA2803282C (en) | 2009-07-06 | 2018-05-01 | David E. Anderson | Methods for preparing vesicles and formulations produced therefrom |
| CN102482666B (zh) | 2009-07-06 | 2017-02-08 | 变异生物技术公司 | 制备囊泡的方法和由其产生的制剂 |
| BR112013017939B1 (pt) * | 2011-01-13 | 2022-11-16 | Variation Biotechnologies Inc | Composição imunogênica liofilizada termoestável, uso e método para preparação da mesma |
| PH12018501678B1 (en) | 2011-08-30 | 2022-08-10 | Astex Pharmaceuticals Inc | Decitabine derivative formulations |
| EP2802353A4 (en) | 2012-01-12 | 2015-12-02 | Variation Biotechnologies Inc | COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS |
| CN104244984B (zh) | 2012-01-27 | 2020-03-31 | 变异生物技术公司 | 用于治疗剂的方法和组合物 |
| DK3283658T3 (da) * | 2015-05-18 | 2020-05-18 | Calimmune Inc | Fremgangsmåder til at diskriminere mellem HIV-1 og lentivirus-vektorer |
| EP3316685A4 (en) | 2015-07-02 | 2019-03-13 | Otsuka Pharmaceutical Co., Ltd. | Lyophilized Pharmaceutical Compositions |
| EP3661522A2 (en) | 2017-08-03 | 2020-06-10 | Otsuka Pharmaceutical Co., Ltd. | Drug compound and purification methods thereof |
| CN113186353A (zh) * | 2021-05-28 | 2021-07-30 | 杭州晶佰生物技术有限公司 | 针对c型逆转录病毒的数字pcr检测用引物及检测方法 |
-
1994
- 1994-10-07 US US08/319,974 patent/US20030104576A1/en not_active Abandoned
-
1995
- 1995-10-05 EP EP95936339A patent/EP0784692A1/en not_active Withdrawn
- 1995-10-05 KR KR1019970702279A patent/KR970706399A/ko not_active Ceased
- 1995-10-05 MX MX9702524A patent/MX9702524A/es unknown
- 1995-10-05 JP JP8512719A patent/JPH10507077A/ja not_active Ceased
- 1995-10-05 NZ NZ295070A patent/NZ295070A/xx unknown
- 1995-10-05 CA CA002201487A patent/CA2201487A1/en not_active Abandoned
- 1995-10-05 CN CN95196131A patent/CN1169161A/zh active Pending
- 1995-10-05 WO PCT/US1995/013219 patent/WO1996011280A1/en not_active Ceased
-
1997
- 1997-04-02 NO NO971495A patent/NO971495L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU707782B2 (en) | 1999-07-22 |
| KR970706399A (ko) | 1997-11-03 |
| CA2201487A1 (en) | 1996-04-18 |
| NO971495D0 (no) | 1997-04-02 |
| JPH10507077A (ja) | 1998-07-14 |
| WO1996011280A1 (en) | 1996-04-18 |
| EP0784692A1 (en) | 1997-07-23 |
| CN1169161A (zh) | 1997-12-31 |
| US20030104576A1 (en) | 2003-06-05 |
| MX9702524A (es) | 1998-02-28 |
| NZ295070A (en) | 1999-11-29 |
| AU3832795A (en) | 1996-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20004104D0 (no) | Preparater omfattende virus og fremgangsmÕter for konsentrering av viruspreparater | |
| FI20080432L (fi) | L-nukleosidejä hepatiitti-B-viruksen ja Epstein-Barr-viruksen hoitamiseksi | |
| NO971495D0 (no) | Svekkede virus og fremgangsmåte til deres fremstilling | |
| EP0859547A4 (en) | VIRUS INACTIVE PACKAGING | |
| NO985196L (no) | Dispergerbare makromolekylblandinger og fremgangsmÕter for deres fremstilli | |
| NO922949D0 (no) | Forbindelser og fremgangsmaater for inhibering av hiv- og beslektede virus | |
| DK0909327T3 (da) | Erythromyciner og fremgangsmåder til deres fremstilling | |
| NO983965D0 (no) | Polymer-organoleire-kompositter og deres fremstilling | |
| NO961160L (no) | Cykliske forbindelser, deres fremstilling og anvendelse | |
| FI971272A7 (fi) | Heikennetty rokotus- ja geenisiirtovirus, menetelmä viruksen valmista miseksi ja virusta sisältävä farmaseuttinen koostumus | |
| NO922275L (no) | Aryletere, deres fremstilling og fremgangsmaate for behandling | |
| AU7501898A (en) | Live attenuated virus vaccines for equine encephalitis viruses | |
| FI955224L (fi) | Hepatiitti-C-virustyypit 4,5 ja 6 | |
| MX9202781A (es) | Vacuna y metodo de tratamiento para virus de inmunodeficiencia humana. | |
| FI964605L (fi) | Hepatiitti-G virus ja sen molekyylikloonaus | |
| DK0991666T3 (da) | Alfa-1-antitrypsin-præparat og fremgangsmåde til fremstilling heraf | |
| NO943794L (no) | 4-difenylmethylpiperidinderivater, og fremgangsmåte for deres fremstilling | |
| IS5777A (is) | Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess | |
| NO941517L (no) | 2-amino-4-kinolin-dihydropyridiner, fremgangsmåter for deres fremstilling og deres anvendelse | |
| NO931246D0 (no) | Sammensetninger for behandling av infeksjon og sykdom foraarsaket av hepatites b virus (hbv) | |
| DK384387A (da) | Erythromycin-derivater til forebyggelse og behandling af sygdomme fremkaldt af virus | |
| BR9506962A (pt) | Cultura seletiva de virus | |
| TR199501690A2 (tr) | Papaya ringspot virüs replikaz geni. | |
| PT841943E (pt) | Virus herpeticos avirulentos uteis como agentes tumoricidas e vacinas | |
| FI944558A0 (fi) | Virus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |